VDRL, Serum (Venereal Disease Research Laboratory) is a blood test used to screen for antibodies associated with syphilis, a sexually transmitted infection caused by Treponema pallidum. It is needed to help identify possible syphilis infection, assess individuals with symptoms or risk factors, and monitor response to treatment. Because VDRL is a non-treponemal test, reactive results are generally confirmed with a specific treponemal test.
Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. Without appropriate treatment, it can progress through different stages and potentially affect multiple organs.
A reactive result indicates that antibodies detected by the test are present. It does not by itself confirm syphilis because false-positive results can occur, so confirmatory testing is usually required.
A non-reactive result means the test did not detect the antibodies measured by the assay. However, very early infection may sometimes produce a negative result.
No. VDRL is a non-treponemal test. A reactive result is generally evaluated with a treponemal-specific test to confirm whether syphilis infection is present.
VDRL detects non-treponemal antibodies associated with cellular damage, while treponemal tests detect antibodies directed more specifically against Treponema pallidum.